TH177311B - Protein fusion - Google Patents
Protein fusionInfo
- Publication number
- TH177311B TH177311B TH1701006531A TH1701006531A TH177311B TH 177311 B TH177311 B TH 177311B TH 1701006531 A TH1701006531 A TH 1701006531A TH 1701006531 A TH1701006531 A TH 1701006531A TH 177311 B TH177311 B TH 177311B
- Authority
- TH
- Thailand
- Prior art keywords
- protein fusion
- insulin
- ocr
- clause
- agonist
- Prior art date
Links
- 230000004927 fusion Effects 0.000 title claims 2
- 102000004169 proteins and genes Human genes 0.000 title claims 2
- 108090000623 proteins and genes Proteins 0.000 title claims 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 claims 4
- 102000004877 Insulin Human genes 0.000 claims 2
- 108090001061 Insulin Proteins 0.000 claims 2
- 239000000556 agonist Substances 0.000 claims 1
- 150000001413 amino acids Chemical group 0.000 claims 1
Claims (1)
Publications (2)
Publication Number | Publication Date |
---|---|
TH177311B true TH177311B (en) | 2018-06-28 |
TH177311A TH177311A (en) | 2018-06-28 |
Family
ID=
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA201792651A1 (en) | Adenoviral polynucleotides and polypeptides | |
BR112017007816A2 (en) | pharmaceutical compositions comprising peptide variants and methods of using them | |
WO2016071376A3 (en) | Fc-region variants with modified fcrn-binding and methods of use | |
DK3707261T3 (en) | Fusion proteins based on human ferritin and protease-cleavable peptides and their use as chemotherapy carriers | |
BR112018013246A2 (en) | peptide label and labeled protein including the same | |
EA201591609A1 (en) | ALPHA-AMILASE OPTIONS | |
TH177311B (en) | Protein fusion | |
TH177311A (en) | Protein fusion | |
EA202090143A1 (en) | PHARMACEUTALLY ACCEPTABLE SALTS OF POLYPEPTIDES AND THEIR APPLICATION | |
TH176997A (en) | CD44v6-derived cyclic peptide for the treatment of cancer and related diseases. With the creation of new blood vessels | |
TH175588A (en) | KZ144 modified endolysin sequence | |
TH178974A (en) | Fusion protein | |
Napetvaridze | The use of history in the process of political science teaching | |
TH182858A (en) | A new protein specific to poverodine and piokily. | |
HD | SUPER-EGO | |
TH179215A (en) | Protein variants of the amino acid sequence Cry1Da1 that are active against Lepidopteran. | |
TH181595A (en) | "TATk-CDKL5 aggregate protein, composition, formulation and application Such things " | |
TH1501004062A (en) | Antifungal polypeptides that cause disease in plants | |
Aliev | THE BOOK OF BURKUN-DARGO. Review on the book by Kurbanov M.-ZY «Burkun-Dargo. History, culture and way of life: the past and the present».-Makhachkala: Nauka-Dagestan, 2015 | |
RU2017122766A (en) | STRAIN E.coli JM109 / pQE80-HSP70-RecEp2 - PRODUCER OF FUSION PROTEIN CONSISTING OF HSPA1B AND HLA-A2 HUMAN RECOVER EPITOPE | |
EA202092327A1 (en) | LFA3 OPTIONS AND THEIR COMPOSITIONS AND APPLICATIONS | |
TH1701005732A (en) | New and holistic peptide and skeletal peptides for use in immunotherapy, anti-cancer of the kidney tissue (RCC) and other cancers. | |
TH174243A (en) | Xylose-containing proteins Isomeres and the use of the same | |
TH1901003157A (en) | trehalose phosphorylase | |
TH180797A (en) | Modified colostrum protein and its use |